The immediate early (IE) genes of human cytomegalovirus (HCMV) are expressed in lymphocytes and are known to transactivate both viral and cellular promoters. The mechanism by which IE gene products of HCMV transactivate expression of the HLA A2 gene promoter in Jurkat cells, a T-lymphocyte cell line, was investigated. Transient expression assays were performed using plasmids containing the HLA A2 promoter-regulatory region linked to the bacterial chloramphenicol acetyltransferase (CAT) gene and a plasmid expressing the CMV IE genes. The upregulation of the HLA A2 promoter by HCVM IE gene products was shown not to be secondary to either interferon-? or UMAN cytomegalovirus (HCMV), a member of the H herpesvirus family, causes subclinical infections in humans and significant illness among immunocompromised patients and transplant recipients. However, despite recent progress in drug therapy of HCMV?' the control of disease produced by HCMV awaits elucidation of its complex interactions with the human immune system.
tion of the IE genes occurs following entry of the virus into the host cell during the first of the temporally regulated phases, reaching a maximum at 4 to 5 hours after infection. Transcription is independent of de novo synthesis of viral proteins. ' The IE genes are known to regulate their own expression [10] [11] [12] [13] [14] [15] [16] and subsequent expression of both early and late viral g e n e~. l~-~" In addition, the IE gene products have been shown to transactivate heterologous promoters. 10,21- 24 The control of the immune response to viral antigens, such as HCMV, is linked to the MHC and HLA complex.2' The HLA complex designates a set of linked genes on chromosome 6 that is highly conserved in evolution. The HLA class I genes encode for products that serve as the target molecules in allogeneic graft rejection and are essential for the recognition of virally infected target cells by sensitized T lymphocytes.26 Studies to date of the induction of class I gene expression by HCMV have been with infectious virus and not the IE genes a l~n e .~~.~' Lymphocytes allow for HCMV entry and expression of the viral IE genes, but these cells are generally nonpermissive and, consequently, late antigens and virus are not dete~table.~.~ On the other hand, monocytes-macrophages are semipermissive and allow for some infectious viral prod~c t i o n .~'
The objective in this investigation was to determine whether or not HCMV IE genes could regulate the expression of class I genes in T lymphocytes in the absence of other viral proteins and, if so, to determine if the effect was a direct effect on the class I gene promoter or was indirectly mediated by lymphokines. In this report, we show that HCMV IE gene products stimulate expression from the HLA A2 promoter in Jurkat cells. This upregulation is not secondary to either interferon-y (IFN-y) or interferon-a (IFN-a). The known class I MHC-specific regulatory and enhancer sites such as the interferon-stimulated response element (ISRE), NF-KB and H2TFI binding sequences, and interferon consensus sequence (ICs) are not necessary for activation ofthe HLA A2 promoter. Instead, the minimal upstream region of the HLA A2 promoter required for transactivation by the HCMV IE gene products contains only the constitutive transcription regulatory elements, the dual CCAAT boxes and TATA box motifs. Jurkat cells were maintained in suspension cultures in RPMl 1640 medium containing 10% fetal calf serum (Hyclone Laboratories, Inc, Logan, VT), 4 mmol/L L-glutamine, and 50 pg of gentamicin per milliliter. The cell line was documented to be free of Mycoplasma.
The plasmid pCS containing the HCMV major IE promoter-regulatory region upstream of the bona fide IEl and IE2 gene regions has been previously described." Synthesis of the HCMV IEI or IE2 proteins from this expression plasmid has been rep01ted.l~
The HLA class 1 plasmid construct, pHLA A2-CAT, was made as follows. A 672-bp fragment was isolated after HindIII and Sma I digestion of pHLA-2a that contained the 5' upstream sequences, presumed CCAAT and TATA boxes, exon 1, and the first 74 bp of intron 1 of the HLA class I A2 gene." This fragment was inserted in the plasmid vector @EM-2 (Promega Biotech, Madison, WI) at the Tissue culture.
Plasmid constructions.
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HZTFl/NF-KB HindIII and Sma I cloning sites and denoted plasmid pHLA A2pGEM-2. Two synthetic oligonucleotides were then prepared; one complementary to the coding strand at the HindIII site of the A2 gene with a HindIII site incorporated into the 5' tail, and the other oligonucleotide complementary to the anticoding strand just prior to the first residue in the first ATG of the A2 gene (designated as + 1 bp) with a 5' Pst I site tail. These oligonucleotides, with pHLA A2pGEM-2 as a primer template, were used in a PCR reaction to generate a 525-bp product that was subjected to Hind111 and Pst I endonuclease digestion. The DNA fragment isolated by agarose gel electrophoresis was inserted in the plasmid vector @EM-1 (Promega Biotech) at the Hind111 and Pst I sites. This plasmid construct, pHLA A2pGEM-1, did not include exon 1 or any intervening sequences of the A2 gene as determined by DNA sequencing. A 1652 bp Pst IBamHI restriction fragment which contained the entire CAT gene was isolated from the plasmid pCAT-Basic (Promega Biotech) and subcloned into the corresponding restriction sites of the pHLA AZpGEM-I plasmid in the correct 5' to 3' orientation with respect to the A2 promoter to generate the plasmid pHLA A2-CAT (Fig I) . The plasmid, K A T , contains the entire CAT gene but no HLA A2 gene sequences.
All 5' internal deletion plasmids were constructed using the method of site-directed mutagenesis by overlap extension with polymerase chain reaction (PCR) as described by Horton et These internal deletions were the ISRE from -405 to -396 bp, the H~TFI/NF-KB (Fig I) . All 5' end deletion plasmids were constructed by PCR by substituting an oligonucleotide primer containing a Hind111 restriction site and complementary to the coding strand of progressively shorter segments of the 5' upstream region of the A2 gene for the first of the two oligonucleotides described above. The consecutive 5' upstream end deletions began at -405, -285, -165, and -116 bp (Fig I) . The sequences of all deletion plasmid constructs were verified by dideoxy~equencing.~~ Oligonucleotides of 35 bp in length were added to a final concentration of I pmol/L to a I 0 0 pL total volume reaction mixture containing 16.6 mmol/L [NH4I2SO4, 67.0 mmol/L tris-hydroxyaminomethane (TRIS)-(pH 8.8), 0.01% (wt/vol) gelatin, 1.5 mmol/ L MgCI,, 67 pmol/L EDTA (pH 8.0), 10.0 mmol/L 2-mercaptoethanol, 10% dimethyl sulfoxide (DMSO), 0.25 mmol/L of each deoxyribonucleoside triphosphate (dNTP), and 0.5 pL (2.5 Us) Taq DNA polymerase. The reaction was cycled at 94°C for 1 minute of denaturation, 50°C for 2 minutes ofannealing, and 72°C for 0.5 minutes of synthesis for a total of 30 cycles. Following PCR, any necessary restriction endonuclease digestion was performed in the PCR reaction buffer, and the PCR product isolated by agarose gel electrophoresis for use in subcloning.
Transfections of Jurkat cells were performed using the DEAE-dextran method.34 The cells were washed twice with RPMI media without supplements and suspended at a concentration of 1 X IO' cells/mL. One milliliter of cells was combined in a 100-mm tissue culture plate with IO mL of RPMI media without supplements, 50 mmol/L TRIS-HCI (pH 7.2), 250 pg/mL DEAE-dextran, and I pg/mL of each plasmid to be transfected. The plates were incubated in a C02 incubator at 37°C for 1 hour. Following the incubation period, the cells were washed once with media containing 1.5 pl/mL of heparin and once with media without supplements. The cells were then suspended in 2 mL of media with supplements per transfection in flat-bottom plates and incubated at 37°C. The cells remained unstimulated for 48 hours or were stimulated with IO ng/mL of PMA and I pg/mL of PHA 24 hours after transfection. All cells were harvested 48 hours after transfection and cell extracts used in the CAT assay.
For analysis of the effect of IFN-7 and IFN-a on the HLA A2 gene promoter, cells were either maintained in IFN-free media or media to which IFN-7 or IFN-a was added beginning 24 hours before transfection or 24 or 36 hours posttransfection. IFN--, was added at doses of 100 or 200 U/mL and IFN-a at 100 U/mL.
CAT assays were performed as described by Gorman et Each CAT assay was standardized to the protein concentration of the cellular extract and the assay was determined at the linear portion of the enzyme reaction. The acetylated derivatives were separated from nonacetylated chloramphenicol by ascending chromatography with a chloroform-methanol (955) solvent and the plates exposed to Kodak XAR-2 film (Eastman Kodak Co, Rochester, NY). For quantitative comparisons, the appropriate sections were cut from the thin-layer chromatography plate, and the amount of radioactivity was measured by liquid scintillation counting. CAT activity was expressed as mean percent conversion of [14C]chloramphenicol to its acetylated derivatives.
Attempts at measuring pHLA A2-CAT mRNA in Jurkat cells by RNase protection assay or primer extension were unsuccessful even though CAT activity was present in the cells. However, the same plasmid construct yielded low levels of correctly initiated A2-CAT mRNA when transfected into K562 or other cell lines, suggesting that steady-state A2-CAT mRNA has different stability in these cell lines (Waring et al, unpublished observations).
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As other investigators have successfully used neomycin phosphotransferase (neoR) gene transcripts to measure mRNA levels when CAT mRNA levels are erratic or cannot be detected,36 we designed a plasmid, pHLA A2-neoR, containing the HLA A2 525 bp 5' upstream promoter region fused to the neoR gene as a reporter gene for use in transfections for mRNA analysis. Two synthetic oligonucleotides, one complementary to the coding strand of the 5' end of the A2 promoter region with an EcoRI site tail and the other complementary to the anticoding strand just prior to the first residue in ATG of the A2 gene with an Xba I site tail, were used in a PCR reaction as earlier described to generate the 525-bp product. This fragment was isolated and inserted in @EM I at the EcoRI and Xba I cloning sites so that the 3' end was located near the Hind111 cloning site. A 2.34-kb neoR Hind111 fragment from plasmid pUC9 was inserted into the Hind111 site in the correct orientation to the A2 promoter. The plasmid used to generate an antisense probe for nuclease analysis was constructed by using the EcoRI oligonucleotide complementary to the coding strand of A2, and a second oligonucleotide complementary to the anticoding strand of neoR with a 5' BamHI site in a PCR reaction with pHLA A2-neoR as the primer template such that a fragment containing the entire A2 promoter and 92 bp of the neoR gene was generated. This fragment was isolated and inserted into the EcoRl and BamHl cloning sites of pGEM I , A uniformly 3ZP-labeled antisense RNA probe was synthesized using SP6 polymerase.
For RNase protection analysis of the initiation start site of the HLA class I A3 gene endogenous to Jurkat cells, plasmid pHLA A2pGEM-2 was used to synthesize a uniformly 32P-labeled antisense RNA probe. This A2 genomic probe protects a 95-nt fragment consisting of 72 nt of exon 1 and 23 nt of the nontranslated 5' flanking sequence and cross-hybridizes with the endogenous HLA A3 class I RNA.
RNA was isolated by a rapid nuclear-cytoplasmic fractionation method at 4°C using diethylpyrocarbonate-treated reagents as previously described.37 Seventy micrograms of RNA, or yeast tRNA as a negative control, was hybridized overnight to IO6 cm of the RNA probe, with subsequent RNase digestion and analysis by electrophoresis as previously de~cribed.'~ RNA, quantitated spectrophotometrically at 260 nm, was glyoxylated by the method of Thomas3* and loaded at approximately 20 pg per lane on 1% agarose gels. Transfer to Gene Screen Plus was by electroblotting. Hybridization to [3ZP]-labeled random primed probes was as previously de~cribed.~' The HLA B7 probe was a 1.4-kb cDNA from clone pDPO0139 and the a-actin probe a I .5-kb cDNA from clone pHMaA-1 .@ Quantitation of bands on autoradiograms was performed by using a Hoefer Scientific Scanning Densitometer model GS 300 (San Francisco, CA) with accompanying software.
Northern (RNA) blot hybridization. To verify that the transcription initiation start site of the transfected A2 gene was located within the A2 promoter, and to demonstrate that pCS(IE I , lE2) increases the steady-state level of the indicator gene RNA, RNase protection analysis of A2-neoR mRNA transcripts was performed. Cells were cotransfected with plasmid pHLA A2-neoR and vector control DNA and remained unstimulated or were cotransfected with pHLA A2-neoR and plasmid pCS(IE1, IE2) and stimulated. Seventy micrograms of RNA was hybridized to a 32P-labeled antisense A2-neoR RNA probe generated by SP6 polymerase.
RESULTS

The HCMV IE gene products transactivate the promoter
As shown in Fig 3A, cotransfection of plasmid pHLA A2-neoR with control DNA resulted in a low level of A2-neoR mRNA in unstimulated cells, with a protected probe fragment length of I 15 nt composed of 92 nt of the neoR gene and 23 nt of nontranslated 5' flanking sequence of the HLA A2 gene (lane I). The band intensity increased markedly in stimulated cells cotransfected with plasmid pHLA A2-neoR and plasmid pCS(IE1, IE2) (lane 2). Densitometric scanning of the autoradiogram showed an eightfold increase in band intensity in the plasmid pCS(IE 1, lE2) cotransfected cells. Therefore, a similar degree of activation of the A2 promoter by HCMV IE gene products was seen at the level of mRNA as observed at the CAT protein level.
To confirm that the initiation start site of the transfected A2 gene was the same as that of endogenous HLA A3 RNA in Jurkat cells, an antisense RNA probe was synthesized from pHLA A2pGEM-2 and used in RNase protection analysis of RNA harvested from unstimulated Jurkat cells. This A2 genomic probe shares homology with the endogenous HLA A3 RNA in the region of transcription initiation. As shown in Fig 3A, lane 3 , this probe protected a 95-nt fragment consisting of 72 nt of exon 1 and 23 nt of the nontranslated 5' flanking sequence. Therefore, the initiation start site from the transfected A2 gene was demonstrated to be identical to the endogenous A3 gene (Fig 3B) . As a control for the dose and potency of IFN used in these studies, the effect of IFN-y or IFN-a on the endogenous class I gene transcription was determined. Cytoplasmic RNA was harvested from cells maintained in IFN-free media or treated with IFN-y or IFN-a in a manner identical to the transfected cells described above. Northern blot analysis was then performed with hybridization to an HLA B7 class I probe. This probe hybridizes with the sequences found in HLA A, B, and C mRNAs endogenous to Jurkat cells. As a control for loading of mRNA, the blots were washed and reprobed to an a-actin probe, as a-actin gene expression has previously been shown to be unaffected by IFN.46 Densitometric scanning was performed and a class I/a-actin ratio calculated to account for the variability in mRNA lane loading. As shown in Fig 5,  IFN- sequences in the regulation of human HLA class I genes is not yet well defined. The location of each of these regulatory and enhancer elements in the promoter-regulatory region of the A2 gene is shown in Fig 1. To determine if one of these known elements is required for HCMV IE-mediated transactivation of the A2 promoter in this assay system. site-directed deletion mutant plasmids were constructed by PCR as described in the Materials and Methods and as illustrated in Fig 1. Cotransfection experiments with the various internal deletion plasmids of the A2 promoter and the plasmid that expresses the IE proteins were done.
IFN-y and
Transactivation ofthe A2 promoter. as determined by CAT assays in either unstimulated or stimulated cells, was not affected by deletion of any or all of these elements (Table I) . For each site deletion. there was a fourfold to sixfold increase in CAT activity in unstimulated cells and an 8-fold to 12-fold increase in stimulated cells. Therefore, it appears that none of these known cis-regulatory elements of class I gene expression are necessary for the upregulation of the A2 gene promoter by HCMV IE gene products in Jurkat cells.
As deletion of known regulatory and enhancer elements failed to identify a cis element required for A2 promoter transactivation by the HCMV IE gene products, we next attempted to determine the minimal cis sequences in the HLA 7 ) . or media to which IFN-u was added at a dose of 100 U/mL (lanes 4 and 8) at 36 hours following transfection. Cells were unstimulated or stimulated with PMA (1 0 ng/mL) and PHA (1 pg/mL) as shown. A2 promoter-regulatory region required for transactivation. 5' end deletion plasmids were constructed so that each contained progressively shorter upstream segments of the HLA A2 promoter-regulatory region. As demonstrated in Fig I , plasmid pHLA A2-CAT 405 contains all known regulatory and enhancer regions. Plasmid pHLA A2-CAT 285 has the ISRE region deleted. The ISRE, H~TF/NF-KB(S), H2TFI/ NF-KB(D). and ICs regulatory regions were deleted in plasmid pHLA A2-CAT 165. Plasmid construct pHLA A2-CAT 1 I6 contains both presumed CCAAT boxes and the presumed TATA box and downstream sequences. Plasmid pCAT contains the entire CAT gene but no HLA A2 gene sequences. Each HLA A2-CAT deletion plasmid was transfected into Jurkat cells with or without plasmid pCS(1EI. IE2). For all plasmid deletion constructs, basal CAT activity and activation by pCS(1EI. IE2) was comparable with the parent plasmid pHLA AZ-CAT in both unstimulated and stimulated cells (Table I ). In contrast. there was only a twofold increase in CAT activity when the control CAT plasmid, pCAT. was cotransfccted with pCS(1EI. IE2). We conclude from these experiments that transactivation of the HLA A2 promoter by HCMV IE gene products requires only the minimal promoter elements.
DISCUSSION
In this study, we have demonstrated that the HLA class I A2 promoter-regulatory region is directly upregulated by HCMV IE gene products in a T-lymphocyte cell line. By RNase protection assay. we confirmed that the transcription start site is within the HLA A2 promoter and that the upregulation of the A2 promoter-regulatory region is accompanied by a similar increase in the steady-state level ofpHLA A2-neoR mRNA. Release of IFN by the T lymphocytes is not responsible for the transfected HLA A2-CAT gene activation. 
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